Close Menu

NEW YORK (GenomeWeb) – Biocartis announced today that it has partnered with AstraZeneca on a European study designed to obtain faster lung cancer molecular diagnostics results.

As part of the agreement, the firms will begin a prospective lung cancer study using Biocartis' Idylla EGFR mutation test in European countries including Belgium, France, Germany, and Italy.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Jun
02
Sponsored by
NanoString

Core facilities support a broad range of scientific studies and must constantly integrate new technologies and analysis to underpin their users’ research. Areas for development include higher multiplex capabilities, greater quantification, correlation to other tools, as well as multi-omics. 

Jun
04
Sponsored by
Ovation

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.